PCM
ALT icon

Polymer Capital Management’s Altimmune ALT Stock Holding History

Polymer Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6K Sell
14,001
-9,998
-42% -$29.9K 0.01% 602
2026
Q1 		$73.9K Buy
+23,999
New +$102K 0.01% 790

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polymer Capital Management's ALT Position: Q2 2026 in Review

Polymer Capital Management reduced its Altimmune (ALT) stake by 42% in Q2 2026, selling an estimated $29.9K and leaving 14,001 shares worth $42.6K. The position accounts for 0.01% of the portfolio, ranked #602.

Polymer Capital Management first reported a position in ALT in Q1 2026 and has held it in 2 quarters since. The position peaked at $73.9K in Q1 2026. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Polymer Capital Management held 14,001 shares of Altimmune worth $42.6K as of Q2 2026.
  • Polymer Capital Management sold 9,998 Altimmune shares in Q2 2026, an estimated $29.9K.
  • Altimmune made up 0.01% of Polymer Capital Management's portfolio in Q2 2026, its #602 holding.
  • Polymer Capital Management first reported a position in Altimmune in Q1 2026 and has held it in 2 quarters since.
  • Polymer Capital Management's Altimmune position peaked at $73.9K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.